CVM Cel Sci Corp
Price (delayed)
$0.396
Market cap
$30.58M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.48
Enterprise value
$34.72M
CEL-SCI believes that boosting a patient’s immune system while it is still intact should provide the greatest possible impact on survival. Therefore, in the Phase 3 study CEL-SCI treated patients
Highlights
The company's EPS rose by 30% YoY and by 6% QoQ
CVM's debt is down by 15% year-on-year and by 4.6% since the previous quarter
Cel Sci's quick ratio has decreased by 17% from the previous quarter but it has increased by 10% YoY
The equity has decreased by 12% from the previous quarter and by 11% YoY
Key stats
What are the main financial stats of CVM
Market
Valuations
Earnings
Shares outstanding
77.21M
Market cap
$30.58M
Enterprise value
$34.72M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.15
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$26.74M
Net income
-$27.94M
EBIT
-$27.23M
EBITDA
-$23.26M
Free cash flow
-$18.14M
Per share
Balance sheet
Liquidity
EPS
-$0.48
EPS diluted
-$0.48
Free cash flow per share
-$0.28
Book value per share
$0.18
Revenue per share
$0
TBVPS
$0.39
Total assets
$25.7M
Total liabilities
$14.39M
Debt
$11.09M
Equity
$11.31M
Working capital
$378,225
Debt to equity
0.98
Current ratio
1.07
Quick ratio
1.27
Net debt/EBITDA
-0.18
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-104.7%
Return on equity
-238.1%
Return on invested capital
-100.3%
Return on capital employed
-134.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CVM stock price
How has the Cel Sci stock price performed over time
Intraday
-6.38%
1 week
-5.04%
1 month
0.58%
1 year
-81.75%
YTD
-0.98%
QTD
-0.98%
Financial performance
How have Cel Sci's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$26.74M
Net income
-$27.94M
Gross margin
N/A
Net margin
N/A
Cel Sci's operating income has increased by 12% YoY
CVM's net income is up by 10% year-on-year
Growth
What is Cel Sci's growth rate over time
Valuation
What is Cel Sci stock price valuation
P/E
N/A
P/B
2.15
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 30% YoY and by 6% QoQ
The stock's price to book (P/B) is 79% less than its 5-year quarterly average of 10.2 and 59% less than its last 4 quarters average of 5.3
The equity has decreased by 12% from the previous quarter and by 11% YoY
Efficiency
How efficient is Cel Sci business performance
CVM's return on equity is down by 17% year-on-year and by 4.2% since the previous quarter
The return on assets has declined by 9% year-on-year and by 4.2% since the previous quarter
Cel Sci's return on invested capital has decreased by 8% YoY and by 8% QoQ
Dividends
What is CVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CVM.
Financial health
How did Cel Sci financials performed over time
The total assets is 79% more than the total liabilities
Cel Sci's current ratio has decreased by 18% from the previous quarter and by 15% YoY
Cel Sci's quick ratio has decreased by 17% from the previous quarter but it has increased by 10% YoY
CVM's debt is down by 15% year-on-year and by 4.6% since the previous quarter
The equity has decreased by 12% from the previous quarter and by 11% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.